Assessment of tissue mitral annular displacement in patients with coronary artery stenosis

Hoorak Poorzand1, Hamidreza Alborz2, Hedieh Alimi3

  • 1Associate Professor, Vascular and Endovascular Surgery Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

ARYA Atherosclerosis
|June 10, 2022
PubMed

Insights

Tissue mitral annular displacement (TMAD) measured by 2D STE is significantly reduced in patients with coronary artery stenosis, correlating with left ventricular function and acute coronary syndrome type. This may help identify the culprit coronary artery.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiac Imaging

Background:

  • Coronary heart disease necessitates early diagnosis for complication prevention.
  • Tissue mitral annular displacement (TMAD) is a key echocardiographic parameter.
  • Assessing TMAD in coronary artery stenosis aids in understanding cardiac function.

Purpose of the Study:

  • To evaluate the mean TMAD using 2D Speckle Tracking Echocardiography (2D STE) in patients with coronary artery stenosis.
  • To correlate TMAD values with left ventricular function and acute coronary syndrome (ACS) types.
  • To explore the potential of TMAD in identifying the culprit coronary artery.

Main Methods:

  • A cross-sectional study included 149 patients (aged 50-76) diagnosed with ACS.
  • TMAD data were acquired using 2D STE technology.
  • Patients were categorized based on culprit artery (LAD, RCA, LCX) and ACS type (STEMI, NSTEMI, unstable angina).

Main Results:

  • TMAD was significantly reduced in walls affected by coronary artery stenosis (LAD, RCA, LCX lesions).
  • TMAD values were notably lower in ST-elevation myocardial infarction (STEMI) compared to NSTEMI and unstable angina.
  • Reduced TMAD was observed in severe left ventricular systolic dysfunction, particularly with LAD lesions.

Conclusions:

  • TMAD shows a significant relationship with left ventricular function, ACS type, and the affected coronary artery.
  • Lower TMAD values indicate worse cardiac function in STEMI subgroups and stenosed artery walls.
  • 2D STE-derived TMAD may serve as a valuable tool for identifying the culprit coronary artery in ACS patients.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
49
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
53
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
54
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
62
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31